| 
				NEUROACTIVE CHEMICALS 
				Neurons in the CNS produce a large number of special molecules 
				which function as neurotransmitters or are suspected to do so, 
				including acetylcholine (ACh), norepinephrine (NE), dopamine 
				(DA), y-aminobutyric acid (GABA), aspartic acid, glutamic acid, 
				glycine, and substance P. CNS neurons also synthesize a number 
				of neuropeptides which perform quite specific endocrine roles. 
				We will take a closer look at these neuroactive chemicals now.
				 
				 Acetylcholine 
				 Acetylcholine has long been recognized as an important 
				neurotransmitter. It's released by preganglionic sympathetic and 
				parasympathetic nerve fiber terminals as well as postganglionic 
				parasympathetic and certain select sympathetic fibers. It is 
				also the only recognized neurotransmitter at the skeletal muscle 
				neuromuscular junction. Unfortunately we don't have nearly as 
				complete a picture of the distribution of cholinergic neurons 
				in the CNS. There appear to be cholinergic fibers associated 
				with the arousal or activating systems of the brain which 
				project from the midbrain reticular formation, hypothalamus 
				striatum, and septum to the neocortex. ACh and the enzymes 
				necessary for its synthesis are also found in the hippocampus, 
				corpus striatum, and retina. 
				 Acetylcholine is formed by the reaction of choline with acetyl 
				coenzyme A (acetyl CoA) in the presence of the enzyme choline 
				acetyltransferase (CAT). Since neurons can't synthesize choline, 
				the ultimate source of choline for ACh synthesis is the choline 
				of the plasma. Acetyl CoA is synthesized within presynaptic 
				cytoplasm by the A TP-energized reaction of acetate with CoA. 
				Once ACH has been synaptically released and has produced its 
				postsynaptic effects on membrane permeability, it is hydrolyzed 
				within microseconds by the enzyme acetylcholinesterase (AChE). 
				Interestingly enough, while negligible amounts of ACh are 
				reabsorbed by presynaptic terminals in the peripheral nervous 
				system (hydrolysis by AChE being overwhelmingly dominant), its 
				reuptake by the terminals in brain is considerable. 
				Nevertheless, its failure to be resequestered into synaptic 
				vesicles leaves the significance of this process in doubt. 
				Acetate + CoA + ATP ~ acetyl CoA + AMP + 2Pi 
				 Catecholamines 
				 The catecholamine neurotransmitters are norepinephrine (NE) and 
				dopamine (DA). The synthesis of both of these amines proceeds 
				from the amino acid tyrosine (Fig. 17-5). Tyrosine is converted 
				to 3,4-dihydroxyphenylalanine (dopa) by the enzyme tyrosine 
				hydroxylase. Subsequent decarboxylation by dopa decarboxylase 
				converts dopa to 3,4-dihydroxyphenylethylamine (dopamine). This 
				is as far as the synthesis proceeds in dopaminergic neurons. In 
				norepinephrinergic neurons, an additional step converts dopamine 
				to norepinephrine by action of the enzyme dopamine ,B-hydroxylase. 
				 The enzymatic degradation of the two catecholamines is 
				illustrated in Fig. 17-6. Catechol-o-methyltransferase (COMT) 
				and monoamine oxidase (MAO) produce inactive products which have 
				little effect on receptor sites. MAO catalyzes the oxidative 
				deamination of norepinephrine to 3,4-dihydroxymandelic acid and 
				dopamine to 3,4-dihydroxyphenylacetic acid. These products are 
				then methylated by COMT to 3-methoxy-4-hydroxymandelic acid and 
				homovanillic acid, respectively. Alternatively, norepinephrine 
				can first be methylated to normetanephrine and then deaminated 
				to 3-methoxy-4-hydroxymandelic acid. 
				 Distribution of Norepinephrinergic Fibers 
				The distribution of norepinephrinergic fibers in the peripheral 
				nervous system is limited to the majority of postganglionic 
				sympathetic neurons. Norepinephrine-releasing neurons in the 
				central nervous system have their cell bodies located in the 
				midbrain, pons, and medulla, primarily in the reticular 
				formation. Two norepinephrine systems are often described in the 
				mammalian brain: the 
				locus ceruleus system 
				and the 
				lateral tegmental system.
				The 
				cell bodies of the former are located in the locus ceruleus, a 
				prominent nucleus in the brain stem reticular formation at the 
				level of the isthmus. This nucleus is composed entirely of 
				norepinephrinergic neurons. Their fibers project to the spinal 
				cord, brainstern, cerebellum, hypothalamus, thalamus, basal 
				telencephalon, and the entire neocortex. The lateral tegmental 
				system includes those norepinephrinergic neurons with cell 
				bodies located in the dorsal motor nucleus of X, the nucleus of 
				the solitary tract, and the adjacent and lateral tegmentum. The 
				fibers of this system project to the spinal cord, brainstem, 
				hypothalamus, thalamus, and basal telencephalon 
				 Distribution of Dopaminergic Fibers 
				Dopaminergic systems in the CNS are more complex, numerous, and 
				diversely distributed than norepinephrine systems. Seven 
				_d_<?fla..!Jl:~I1.e~gj£ systems can be identified III the 
				mammalian brain.  
				Nigrostriatal 
				System The 
				neurons in this system project from the pars compacta of the 
				substantia nigra and the mediolateral tegmentum to terminate in 
				the caudate nucleus, putamen, and globus pallidus. A marked 
				reduction in dopamine content in the neostriatum (caudate and 
				putamen) is characteristic in patients with Parkinson's disease. 
				There is good evidence that the dopaminergic neurons of the 
				substantia nigra inhibit their target cells in the caudate 
				nucleus.  
				Mesocortical 
				System 
				This system is composed of fibers from the substantia nigra and 
				medioventral tegmentum which do not project to the basal nuclei. 
				The fibers terminate in both the neocortex and allocortex. 
				Terminations in the former include the mesial frontal, anterior 
				cingulate, entorhinal, and perirhinal regions. Terminations in 
				the allocortex include the olfactory bulb, anterior olfactory 
				nucleus, olfactory tubercle, piriform cortex, septal area, and 
				amygdaloid complex.  
				Tuberohypophyseal 
				System 
				These fibers originate in the arcuate and periventricular 
				hypothalamic nuclei, and project to the neurointermediate lobe 
				of the pituitary gland as well as the median eminence. One 
				function of this system appears to be the inhibition of 
				pituitary prolactin secretion. The pathway to the intermediate 
				lobe may serve to inhibit melanocyte-stimulating hormone (MSH) 
				secretion.  
				Retinal System
				The 
				dopaminergic neurons of this system are the interplexiform 
				cells of the retina which terminate in both the inner and outer 
				plexiform layers of the retina.  
				
				Incertohypothalamic System 
				These fibers project 
				from the zona incerta and the posterior hypothalamus to the 
				dorsal hypothalamic area and the septum. They may playa role in 
				neuroendocrine regulation.  
				Periventricular 
				System The 
				cell bodies of these fibers are located in the medulla in the 
				area of the dorsal motor nucleus of X, the nucleus of the 
				solitary tract, and the periaqueductal and periventricular gray 
				matter. They terminate in the periaqueductal and periventricular 
				gray, tegmentum, tectum, thalamus, and hypothalamus. Their 
				function is unknown.  
				Olfactory Bulb 
				System 
				This system is composed of the periglomerular cells of the 
				olfactory bulbs which terminate on the mitral cells of the 
				glomeruli. Their function is unknown. 
				 Serotonin and Melatonin 
				 Serotonin 
				and melatonin are neuroactive indolealkylamines. Serotonin 
				functions as a CNS neurotransmitter while melatonin, formed by a 
				two-step process from serotonin, may playa hormonal role in the 
				pineal gland. The highest concentration of serotonin anywhere in 
				the body is in the pineal gland. The next highest concentration 
				is in the raphe nuclei of the lower brainstem. The French 
				neurophysiologist Jouvet demonstrated the role of these 
				serotonergic raphe neurons by performing experiments on cats. He 
				selectively destroyed the raphe neurons, producing a 
				significant reduction in brain serotonin levels, and found that 
				the cats became totally insomniac. He followed this by 
				administering p-chlorophenylalanine to another group of cats. 
				This drug, which prevents the conversion of tryptophan to 
				5-hydroxytryptophan by interfering with the action of the enzyme 
				tryptophan hydroxylase, decreases the raphe concentration of 
				serotonin, because 5-hydroxytryptophan is a serotonin 
				precursor. This group of cats also became insomniac. Subsequent 
				administration of 5-hydroxytryptophan reversed the insomnia, 
				putting the cats to sleep. 
				 Melatonin 
				is formed from serotonin in the pineal gland by acetylization to 
				n-acetyl serotonin by 5_hydroxytryptamin~-n-acetylase. The 
				enzyme 5hydroxyindole-o-methyl transferase then completes the 
				conversion to melatonin. The synthesis of both serotonin and 
				melatonin, as well as the degradation of serotonin, are 
				illustrated in Fig. 17-7   |